The NCRI TYA & Germ Cell Tumours Group brings together clinicians, scientists and patients, carers and others affected by cancer (also known as ‘consumers’), amongst many others, to coordinate the development of a strategic portfolio of research within the field of teenage and young adult and germ cell tumours. The group works closely with clinical research networks, funders and researchers to develop research to improve outcomes for teenage and young adult and germ cell tumour patients.  

The NCRI TYA & Germ Cell Tumours Group consists of an executive group, chaired by Professor Dan Starkwhich provides oversight of the research landscape and proactively identifies opportunities for the group. The NCRI TYA & Germ Cell Tumours Group also has several subgroups that develop research in areas of strategic need. Members are competitively recruited to the executive group and subgroups twice a year.  

The NCRI TYA & Germ Cell Tumours Group was formed when the NCRI Teenage & Young Adults (TYA) Group and NCRI Testis Groups merged in 2017. 

Group Chair: Dr Dan Stark

Shamaila Anwar, NIHR CRN Specialty Cluster Manager (Cancer, Surgery and Oral & Dental Health), National Institute for Health Research (NIHR)

Gladstone Amos Burke, NIHR CRN: Cancer National Specialty Lead for Children & Young People’s Cancer, University of Cambridge

Ben Carpenter, TYA and Adult Consultant Haematologist, University College London Hospitals NHS Foundation Trust (UCLH)

Anna Castleton, Consultant in adult/TYA Haematology and BMT, Christie NHS Foundation Trust

Maria Antonietta Cerone, Post-Doc, Cancer Research UK (CRUK) London – Clinical Trials Unit @ University College London (UCL)

Julia Chisholm, Consultant in Paediatric and TYA Oncology, Royal Marsden NHS Foundation Trust

Paul Chumas, Surgeon, Leeds Teaching Hospitals NHS Trust – Leeds General Infirmary

David Cutter, Consultant Clinical Oncologist and Clinical Research Fellow, Oxford University Hospitals NHS Foundation Trust

Richard Feltbower, Senior Lecturer, University of Leeds

Lorna Fern, Teenage and Young Adult Clinical Studies Group Research Development Coordinator, National Cancer Research Institute (NCRI)

Ben Fulton, Clinical Oncologist, NHS Greater Glasgow and Clyde

Adam Woolf Glaser, Professor of Paediatric Oncology & Late Effects, University of Leeds

Hadeel Hassan, Clinical Research Fellow, University of Leeds

Mike Hawkins, Professor of Epidemiology and Director of the Centre for Childhood Cancer Survivors Studies, King’s College London (KCL)

Bethan Ingram, Advanced Nurse Practitioner, Haematology & TYA Cancer, Cardiff and Vale University Health Board (CVUHB)

Angela Jesudason, Consultant Paediatric Oncologist, Edinburgh Sick Children’s NHS Trust

Matthew Murray, Consultant, University of Cambridge

Nicola Pettitt, Teenage Cancer Trust Nurse Consultant, University Hospitals Birmingham NHS Foundation Trust

Sarah Pratap, Oxford University Hospitals NHS Foundation Trust

Carla Reid, Oncology Physiotherapist, Royal Marsden NHS Foundation Trust

Alison Reid, Royal Marsden NHS Foundation Trust

Naveed Sarwar, Trials Lead, Imperial College Healthcare NHS Trust – St Mary’s Hospital

Sheona Scales, ECMC Paediatric Network Manager, Cancer Research UK (CRUK)

Jonathan Shamash, Barts Health NHS Trust

Louise Soanes, Teenager Cancer Trust Nurse Consultant for Adolescents & Young Adults, University College London Hospitals NHS Foundation Trust (UCLH)

Dan Stark, Professor, Consultant Medical Oncologist – Teenagers and Young Adults with Cancer, Testicular cancer, Sarcomas of Soft Tissue and, University of Leeds

Sara Stoneham, University College London Hospitals NHS Foundation Trust (UCLH)

Graham Wheeler, Senior Statistician, University College London (UCL)

Graham Wheeler, Senior Statistician, University College London (UCL)

Max Williamson

Rachael Windsor, University College London Hospitals NHS Foundation Trust (UCLH)

Vincent Wolverson